Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
Morning Overview on MSN
Brain-computer interface startups surge after three companies secure FDA breakthrough device designation in 2026
In the first four months of 2026, three brain-computer interface companies earned FDA Breakthrough Device Designation, a ...
AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...
Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...
Apple is collaborating with brain-computer interface company Synchron to develop technology that lets users control devices using neural signals. “This marks a defining moment for human-device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results